Clinical trial
Effects of the Diacutaneous Fibrolysis Approach on Gastrocnemius Length, Plantar Fascia Viscoelasticity and Plantar Arch Diameters in Patients With Plantar Fasciitis.
NCT05075434 is registered in ClinicalTrials.gov with Universitat Internacional de Catalunya as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of the Diacutaneous Fibrolysis Approach on Gastrocnemius Length, Plantar Fascia Viscoelasticity and Plantar Arch Diameters in Patients With Plantar Fasciitis.
- Lead sponsor
- Universitat Internacional de Catalunya
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- January 1, 2022
- Completion date
- June 1, 2023
- Enrollment
- 32 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
heel pain syndrome, plantar fascitis